Eagle Veterinary Technology (044960): Korean Industrials stock

What the company does

Eagle Veterinary Technology makes and imports medicines for livestock and companion animals, including injectable drugs, water-soluble powders, feed additives, antibiotics, antiparasitic treatments, vitamins, and vaccines, used to prevent and treat disease in cattle, pigs, and poultry.

Its customers are livestock farmers and the broader Korean animal-husbandry supply chain. Listed on KOSDAQ, Korea's small-cap tech board, the company both manufactures and imports the full range of veterinary drug formats it supplies to the market.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$31.4M

▲ +3.9% YoY

Operating profit · FY2025

US$3.1M

▲ +22.9% YoY

Net income · FY2025

US$2.9M

▲ +6.5% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$31M(₩42.8B)	US$30.2M(₩41.7B)	US$31.4M(₩43.3B)
Operating profit	US$2.4M(₩3.3B)	US$2.5M(₩3.5B)	US$3.1M(₩4.3B)
Net income	US$2.2M(₩3B)	US$2.7M(₩3.7B)	US$2.9M(₩3.9B)

Revenue

FY2023US$31M
FY2024US$30.2M
FY2025US$31.4M

Operating profit

FY2023US$2.4M
FY2024US$2.5M
FY2025US$3.1M

Net income

FY2023US$2.2M
FY2024US$2.7M
FY2025US$2.9M

Key ratios (FY2025)

ROE

7.6%

Debt/Eq

23.3%

Op. margin

9.8%

Net margin

9.1%

Rev. YoY

▲ +3.9%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?